NCT06465901View on ClinicalTrials.gov

A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI

NANot yet recruitingINTERVENTIONAL
Enrollment

10,092

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

September 30, 2026

Conditions
Surgical Site Infection
Interventions
OTHER

Chlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower

Chlorhexidine Gluconate 2.0% to 4.0% (e.g. Hibiscrub) preoperative shower

OTHER

Intraoperative wound wash (e.g. Granudacyn)

Intraoperative wound wash (e.g. Granudacyn)

OTHER

DACC surgical wound dressing (e.g. Leukomed Sorbact)

DACC surgical wound dressing (e.g. Leukomed Sorbact)

Trial Locations (7)

91700

Hospital Espanola Veracruz, Veracruz

141008

Christian Medical College (CMC) & Hospital, Ludhiana, Ludhiana

Unknown

University of Abomey-Calavi, Abomey-Calavi

Tamale Teaching Hospital, Tamale

Lagos University Teaching Hospital (Hub), Lagos

University Teaching Hospital of Kigali (Hub), Kigali

University of the Witwatersrand, Johannesburg

All Listed Sponsors
collaborator

Kigali University Teaching Hospital

OTHER

collaborator

Université d'Abomey-Calavi

OTHER

lead

University of Birmingham

OTHER

NCT06465901 - A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI | Biotech Hunter | Biotech Hunter